Safe and Effective Method of Treating Psoriasis with Anti-IL-23 Specific Antibody

• 收藏
• 分享

专利权人:

Janssen Biotech; Inc.

发明人:

Julianty Angsana,Patrick Branigan,Samuel DePrimo,Susan Flavin,Shu Li,Xuejun Liu,Ernesto Munoz,Bruce Randazzo

申请号：

US16688178

公开号：

US20200157209A1

申请日:

2019.11.19

申请国别(地区):

US

年份:

2020

代理人:

摘要：

A method of treating psoriasis in a patient by administering an IL-23 specific antibody, e.g., guselkumab, in a clinically proven safe and clinically proven effective amount and the patient achieves PASI90, PASI100 or IGA 0 or 1 score as measured 16, 24, 32, 40 and 48 weeks after initial treatment and the patient achieves higher efficacy than a patient treated with the secukinumab antibody

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/